Aviance Capital Partners’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.93M Sell
12,644
-245
-2% -$104K 0.51% 45
2026
Q1
$6.1M Sell
12,889
-232
-2% -$117K 0.71% 28
2025
Q4
$6.13M Sell
13,121
-38
-0.3% -$17.6K 0.71% 26
2025
Q3
$5.61M Buy
13,159
+155
+1% +$60.1K 0.67% 28
2025
Q2
$4.98M Buy
13,004
+22
+0.2% +$7.93K 0.65% 33
2025
Q1
$4.49M Buy
12,982
+1,885
+17% +$606K 0.63% 37
2024
Q4
$3.33M Buy
11,097
+3,468
+45% +$1.21M 0.46% 47
2024
Q3
$3.1M Sell
7,629
-54
-0.7% -$19.8K 0.41% 50
2024
Q2
$2.47M Buy
7,683
+58
+0.8% +$18.8K 0.35% 69
2024
Q1
$2.54M Buy
+7,625
New +$2.33M 0.38% 64

Other funds holding HCA

Aviance Capital Partners's HCA Position: Q2 2026 in Review

Aviance Capital Partners reduced its HCA Healthcare (HCA) stake by 1.9% in Q2 2026, selling an estimated $104K and leaving 12,644 shares worth $4.93M. The position accounts for 0.51% of the portfolio, ranked #45.

Aviance Capital Partners first reported a position in HCA in Q1 2024 and has held it in 10 quarters since. The position peaked at $6.13M in Q4 2025. 1,339 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Aviance Capital Partners held 12,644 shares of HCA Healthcare worth $4.93M as of Q2 2026.
  • Aviance Capital Partners sold 245 HCA Healthcare shares in Q2 2026, an estimated $104K.
  • HCA Healthcare made up 0.51% of Aviance Capital Partners's portfolio in Q2 2026, its #45 holding.
  • Aviance Capital Partners first reported a position in HCA Healthcare in Q1 2024 and has held it in 10 quarters since.
  • Aviance Capital Partners's HCA Healthcare position peaked at $6.13M in Q4 2025.
  • 1,339 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Aviance Capital Partners's 13F filing for Q2 2026, filed 31 Jul 2026.